Financing
Photogen announces revised $9 million financing
Published in Cancer Weekly, November 26th, 2002
As revised, the company will sell at least $9.0 million common stock at $0.27 per share. All other terms of the financing remain unchanged. Investors in the transaction include Mi3 LP of Wellesley MA and Oxford Biosciences of Boston.
This financing, and other related transactions, including a restructuring plan to focus the company's efforts on cardiovascular imaging and lymphography, will be subject to shareholder approval.
Photogen Technologies, Inc. is developing a platform of products with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2002-11-26)
More Articles from Cancer Weekly
- Kidney Cancer
Combination of cytotoxic and antiangiogenic agents diminish renal carcinoma - Melanoma
Research report shows new approach to replacing immune cells to shrink tumors - Cancer Therapy
AntiHIV agent active against malignant cells - Cancer Therapy
Tailor-made cancer drugs: Wave of the future? - Cancer Vaccine
Method to transduce leukemia B cells developed - Hepatocellular Carcinoma
Antisense nucleotides keep cancer cell proliferation in check - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
